News Briefing channel feed – Endpoints News

News Briefing channel feed

Peregrine slashes R&D in a reorg that claims 60 jobs; Zai Labs in hunt for $150M IPO - report

8 years ago

Takeda strikes a combo I/O discovery pact with Shattuck Labs; Facing FDA rejection, Egalet slashes staff

8 years ago

Ardelyx brings out the ax, chopping 28% of staffers; PRA bags Symphony Health Solutions in $530M acquisition

8 years ago

Aclaris bags St. Louis biotech for $20M; Pfizer investing $100M in gene therapy work

8 years ago

FDA slams Vernalis with 2nd CRL in 3 months; Former Shkreli company KaloBios changes name

8 years ago

Post-merger, Indalo raises $9M; Spark raising $331M; No word on Shkreli’s fate

8 years ago

Teva talks tough on cuts; Takeda bolsters startup with a dedicated cardio discovery team

8 years ago

Ocular cuts staff in wake of FDA slapdown; Biogen recruits Pfizer vet; X4 inks discovery deal with Yale

8 years ago

Lexicon grabs co-promo option on diabetes drug; Shkreli jury enters second day of deliberations

8 years ago

AstraZeneca bags a ‘breakthrough’ for bruised checkpoint drug Imfinzi; Inotek CSO takes the helm at Flex

8 years ago

Idorsia touts new sleep drug data ahead of PhIII; Tetraphase out to raise $65M

8 years ago

Intellipharmaceutics shares crushed as FDA experts snub pain drug; Moncef Slaoui joins Moderna board

8 years ago

Kezar bags a $50M B round in wake of PhIa study; Bayer kicks back a partnered drug

8 years ago

Sarepta raising $325M; Astellas joins the big migration to Cambridge, MA

8 years ago

Samsung Bioepis launches a Remicade knockoff at a 35% discount; FDA OK’s a self-administered version of Benlysta

8 years ago

Takeda explores computational chemistry leads from Schrödinger in $170M-plus pact; Aeterna Zentaris boots CEO, considers options

8 years ago

Trevi gets $50M and David Meeker as its new chairman; Spark in line for a PRV

8 years ago

European watchdog wants to manage “risks” of early contacts between regulators, biopharma

8 years ago

Takeda shifting hundreds of R&D staffers to Boston — report; Shire inks hemophilia deal; Amgen, Array partner on autoimmune diseases

8 years ago

Strongbridge raises $53M in financing; Sienna Bio sets terms for $70M IPO

8 years ago

Mylan, Amgen score unanimous AdComm backing for Roche copycats; Alder raises $161M

8 years ago

Merck KGaA life sciences reorg will claim 200 jobs; Tesaro shares sink on new report discounting buyout talk

8 years ago

Erytech collaborates on rare disease drug; Enterome creates diagnostics venture with Nestlé

8 years ago

Neothetics sheds staff, looks for survival strategy in wake of trial failure; GSK walks away from OncoMed pact

8 years ago

First page Previous page 67 68 697071 72 73 Next page Last page